Ticker Symbol: SZGEF
SenzaGen AB
Exchange: US OTC
Country:
SE
Currency:
USD
Asset
Type: Common Stock
Company Profile
SenzaGen AB engages in the development of in vitro test methods for prediction of chemical and protein sensitizers. The firm offers services for assessment of sensitizers for industry and regulatory purposes, using its proprietary technology called GARD - Genomic Allergen Rapid Detection. Its serves clients in cosmetic, chemical, pharmaceutical, and food industries. The company was founded by Malin Marie Lindstedt and Carl Arne Krister Borrebaeck, in August 18, 2010 and is headquartered in Lund, Sweden.
Sector: Health Technology
Industry: Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: Medicon Village
Website: http://www.senzagen.com
CEO: Axel Sjöblad
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: - - $1.70
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 23648330
Valuation
Market Cap: 4.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A